Biocytogen Pharmaceuticals Beijing Co Ltd 2315.HK:Hong Kong Stock Exchange

*Data is delayed | Exchange | HKD
Last | 3:32 PM CTT
8.90quote price arrow up+0.19 (+2.18%)
Volume
103,000
52 week range
5.74 - 27.80
Loading...
  • Open8.77
  • Day High9.00
  • Day Low8.62
  • Prev Close8.71
  • 52 Week High27.80
  • 52 Week High Date05/03/23
  • 52 Week Low5.74
  • 52 Week Low Date04/11/24

Key Stats

  • Market Cap423.49M
  • Shares Out399.4M
  • 10 Day Average Volume124,187.5
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-25.71

KEY STATS

  • Open8.77
  • Day High9.00
  • Day Low8.62
  • Prev Close8.71
  • 52 Week High27.80
  • 52 Week High Date05/03/23
  • 52 Week Low5.74
  • 52 Week Low Date04/11/24
  • Market Cap423.49M
  • Shares Out399.4M
  • 10 Day Average Volume124,187.5
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-25.71

RATIOS/PROFITABILITY

  • EPS (TTM)-1.06
  • P/E (TTM)-8.41
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biocytogen Pharmaceuticals Beijing Co Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Biocytogen Pharmaceuticals Beijing Co Ltd is a China-based company mainly engaged in drug development business and preclinical research. The Company operates two business segments. The Drug Development Business segment is mainly engaged in the research and development of oncology and autoimmune disease treatments, as well as antibody development. The Preclinical Research Service segment is mainly engaged in gene editing, preclinical pharmacological efficacy evaluation and...
Yuelei Shen
Executive Chairman of the Board, Chief Executive Officer, General Manager
Bin Liu
Chief Financial Officer
Address
No. 12
Baocan South Street, Daxing District
Beijing, BEJ
101111
China